Amanote Research
Register
Sign In
639. Combination Therapy of Bufalin and rAd-p53 for the Treatment of Hepatocellular Carcinoma in Vivo
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)34248-4
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2015
Authors
Lina Wang
Chen Ling
Meng Wang
Zifei Yin
Changquan Ling
Min Li
Publisher
Elsevier BV
Related search
The Synergistic in Vitro and in Vivo Antitumor Effect of Combination Therapy With Salinomycin and 5-Fluorouracil Against Hepatocellular Carcinoma
PLoS ONE
Multidisciplinary
Provocative Gene Therapy Strategy for the Treatment of Hepatocellular Carcinoma
Hepatology
Medicine
Hepatology
Combined Modality Doxorubicin-Based Chemotherapy and Chitosan-Mediated P53 Gene Therapy Using Double-Walled Microspheres for Treatment of Human Hepatocellular Carcinoma
Biomaterials
Mechanics of Materials
Biophysics
Biomaterials
Bioengineering
Composites
Nanoscience
Nanotechnology
Ceramics
Gene Therapy for Hepatocellular Carcinoma.
SEIBUTSU BUTSURI KAGAKU
P05 Combination of Serum Biomarkers for the Diagnosis of Hepatocellular Carcinoma
Gut
Gastroenterology
In Vivo Assessment of the Spatial Distribution of Liver Injury Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Locoregional and Systemic Therapy for Hepatocellular Carcinoma
Journal of Gastrointestinal Oncology
Oncology
Gastroenterology
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Targeted Therapy in Hepatocellular Carcinoma
International Journal of Hepatology
Hepatology
